Centricity Research Columbus Endocrinology is a clinical research site located in Columbus, Georgia, United States 31904.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Centricity Research Columbus Endocrinology has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Type 2 Diabetes, Type 2 Diabetes Mellitus, Diabetic Peripheral Neuropathic Pain.
Sponsors: Eli Lilly and Company, Reata, a wholly owned subsidiary of Biogen.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Georgia · View every site in Columbus
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Centricity Research Columbus Endocrinology has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Centricity Research Columbus Endocrinology has 3 clinical trials on record, with 1 currently active. Their work covers Type 2 Diabetes, Type 2 Diabetes Mellitus, Diabetic Peripheral Neuropathic Pain.
Centricity Research Columbus Endocrinology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.